announcing schrödinger first discovery 2.0
TRANSCRIPT
Announcing Schrodinger
FirstDiscovery 2.0
Schrodinger is pleased to announce FirstDiscovery 2.0, a major upgrade of
its premier integrated suite for structure-based drug design.
FirstDiscovery employs the latest computational chemistry technology to
accelerate the discovery and optimization of leads in pharmaceutical
research. It combines the most accurate simulations with an easy-to-use
interface that facilitates visualization, analysis, and project management.
The suite consists of three integrated modules:
• Glide: High-throughput ligand-receptor docking for fast library screening
• Liaison: Ligand-receptor binding free energies for lead optimization
• QSite: Mixed QM/MM for reactive chemistry at the enzyme active site
FirstDiscovery 2.0 features enhanced scoring functions that improve
enrichment factors, particularly for kinases, as well as lowered memory
requirements and significant increases in processing speed. The upgraded
package will be available summer 2002. We invite you to contact us and
arrange for an onsite evaluation.
Schrodinger 503.299.1150
www.schrodinger.com
Get there first.